CORSAIR CAPITAL MANAGEMENT, L.P.

Position in LQDA — Liquidia Corp

CIK 1276470 NEW YORK, NY

Back to LQDA Full portfolio

Position in LQDA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,195,950

+$629,850 QoQ

Shares Held

15,000

0.0% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#157

of 334 holders

Holding Since

Mar 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in LQDA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CORSAIR CAPITAL MANAGEMENT, L.P. holds $2,321,580 across 4 Drug Manufacturers - Specialty & Generic names. LQDA ranks #1 (51.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp This page	15,000	$1,195,950
2	HROW	Harrow, Inc.	19,000	$806,930
3	AQST	Aquestive Therapeutics, Inc.	70,000	$291,200
4	RMTI	Rockwell Medical, Inc.	5,000	$27,500

All Filings in LQDA

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,195,950	15,000	0.0%	Shares	Sole	2026-08-14
2026-03-31	$566,100	15,000	-25.0%	Shares	Sole	2026-05-15
2025-12-31	$689,800	20,000	+100.0%	Shares	Sole	2026-02-17
2025-03-31	$147,500	10,000	—	Shares	Sole	2026-04-21
No filing history on record for this holder in this stock.